Xponance’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Xponance’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-35	Closed	-$17K	–	1253
2021 Q2	$17K	Buy	+35	New	+$18.8K	﹤0.01%	1245

Other funds holding AMPE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Xponance's AMPE Position: Q3 2021 in Review

Xponance sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2021, closing a stake of 35 shares — an estimated $17K sold.

Xponance first reported a position in AMPE in Q2 2021 and held it in 1 quarter. The position peaked at $17K in Q2 2021. 121 funds tracked by Wall St. Rank hold AMPE as of Q3 2021.

Xponance reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2021 after selling out during the quarter.
Xponance sold 35 Ampio Pharmaceuticals Inc. shares in Q3 2021, an estimated $17K.
Xponance first reported a position in Ampio Pharmaceuticals Inc. in Q2 2021 and held it in 1 quarter.
Xponance's Ampio Pharmaceuticals Inc. position peaked at $17K in Q2 2021.
121 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2021.

Based on Xponance's 13F filing for Q3 2021, filed 5 Nov 2021.